Related references
Note: Only part of the references are listed.Inflammation, cardiovascular disease, and cancer: a common link with far-reaching implications
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL (2019)
Atrial Fibrillation in the Era of Emerging Cancer Therapies
Avirup Guha et al.
EUROPEAN HEART JOURNAL (2019)
Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study
Christina Boegh Jakobsen et al.
BMC CANCER (2019)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms
Joachim Alexandre et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic Strategies
Antonella Tufano et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Case-non case studies: Principles, methods, bias and interpretation
Jean-Luc Faillie
THERAPIE (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Ibrutinib-Associated Atrial Fibrillation
Sarju Ganatra et al.
JACC-CLINICAL ELECTROPHYSIOLOGY (2018)
Cardiovascular Complications of Cancer Therapy Best Practices in Diagnosis, Prevention, and Management: Part 2
Hui-Ming Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery The PRESAGE Trial
Daniela Cardinale et al.
ANNALS OF SURGERY (2016)
The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis
Darryl P. Leong et al.
BLOOD (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Javid J. Moslehi
NEW ENGLAND JOURNAL OF MEDICINE (2016)
French pharmacovigilance: Missions, organization and perspectives
Thierry Vial
THERAPIE (2016)
Association of Atrial Fibrillation and Cancer
Faisal Rahman et al.
JAMA CARDIOLOGY (2016)
The Impact of Atrial Fibrillation on Subsequent Survival of Patients Receiving Ibrutinib As Treatment of Chronic Lymphocytic Leukemia (CLL): An International Study
Philip A. Thompson et al.
BLOOD (2016)
Relation Between Cancer and Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study)
Wesley T. O'Neal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
Juan Tamargo et al.
DRUG SAFETY (2015)
Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
Sumeet S. Chugh et al.
CIRCULATION (2014)
Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank
Ola Caster et al.
DRUG SAFETY (2014)
Insights Into Onco-Cardiology Atrial Fibrillation in Cancer
Dimitrios Farmakis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Mitochondrial Dysfunction as an Arrhythmogenic Substrate
David Montaigne et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Drug-induced atrial fibrillation
Juan Tamargo et al.
EXPERT OPINION ON DRUG SAFETY (2012)
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Adverse drug reactions: definitions, diagnosis, and management
IR Edwards et al.
LANCET (2000)
Basic mechanisms of atrial fibrillation - Very new insights into very old ideas
S Nattel et al.
ANNUAL REVIEW OF PHYSIOLOGY (2000)
Share Paper
